Literature DB >> 4107054

[In-vitro changes of the serum binding capacity for 131 I-insulin under tolbutamide and glybenclamide in normal persons, in juvenile and senile diabetes, as well as in insulin resistance].

K Schemmel, E Haupt, K Leybold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4107054     DOI： 10.1007/bf01487013

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  6 in total

1.  [INSULIN ACTIVITY OF PROTEIN FRACTIONS OF NORMAL HUMAN SERUM].

Authors:  H DITSCHUNEIT; R CUENDET; E F PFEIFFER
Journal:  Pathol Biol       Date:  1964-02

2.  [Current problems of diabetes therapy].

Authors:  E F PFEIFFER; H DITSCHUNEIT
Journal:  Dtsch Med Wochenschr       Date:  1962-11-09       Impact factor: 0.628

3.  [Sulfonamides modifying insulin secretion and the development of the islands of Langerhans. Actions and antagonisms of actions. Some experimental studies of their clinical applications].

Authors:  A Loubatières; M M Mariani; R Alric
Journal:  Bull Acad Natl Med       Date:  1967-12-19       Impact factor: 0.144

4.  [Separation of protein bound and free diffusible serum calcium using Sephadex].

Authors:  H M von Hattingberg; W Klaus
Journal:  Klin Wochenschr       Date:  1966-05-01

5.  Insulin-regulatory mechanisms and diabetes mellitus. Effect of tolbutamide on the insulin-regulatory mechanisms.

Authors:  H N ANTONIADES; J A BOUGAS; R CAMERINI-DAVALOS; H M PYLE; S J MAZURKIE; O LOZANO-CASTANEDA; A MARBLE
Journal:  N Engl J Med       Date:  1963-08-22       Impact factor: 91.245

6.  Studies on the state of insulin in blood. Examination of splenic, portal and peripheral blood serum of diabetic and nondiabetic subjects for "free" insulin and insulin complexes.

Authors:  H N ANTONIADES; J A BOUGAS; H M PYLE
Journal:  N Engl J Med       Date:  1962-08-02       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.